Open access
Sep 2026
Integrated in silico and in vitro profiling of newly designed heterocyclic thiazolidinone targeting androgen-independent prostate cancer
The combined in silico in vitro strategy was found to be useful in expediting anticancer lead discovery, and it aids in using computational-experimental pipelines in rational drug design.
Z. Al-Khazragie, Mayada Sabri, Luma Sabri et al.
· Babcock University Medical J... · 0 citations